Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clopidogrel and Aspirin After CABG Surgery
NCT00776477Phase 3Unknown
- Sponsor
- National Center for Cardiovascular Disease
- Start
- Dec 2007
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of clopidogrel in saphenous vein graft disease (SVGD), sponsored by National Center for Cardiovascular Disease. Status: unknown.
02
Drugs
clopidogrel
03
Conditions
saphenous vein graft disease (SVGD)
Beyond the preview
Go deeper on NCT00776477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00776477.